Relpax Recall Issued Over Potential Microbial Contamination
Two lots of Relpax, a migraine medication, are being recalled because of the risk of bacterial contamination.
August 16, 2019 By: Martha Garcia
Two lots of Relpax, a migraine medication, are being recalled because of the risk of bacterial contamination.
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.
A $479 million Philips CPAP class action settlement agreement will resolve claims of economic loss filed by users of the recalled devices.